US poised to negotiate drug prices despite fierce pharma lobbying
Por um escritor misterioso
Descrição
Makers of blockbuster drugs including Eli Lilly, AbbVie and AstraZeneca face new curbs
An Analysis of the Blizzard of Lawsuits to Block Drug-Price
How PhRMA is trying to thwart Democrats' effort to lower drug prices
Pharma bemoans drug pricing bill as patient advocates celebrate
Biden Administration Unveils First Drugs for Medicare Price
This Is Why Your Drug Prescriptions Cost So Damn Much – Mother Jones
Pharma lobby furious over wildly popular effort to curb drug
A bitter pill: how big pharma lobbies to keep prescription drug
/s3.amazonaws.com/arc-authors/reuters/0b82a826-fb3f-4043-b864-a941ebaf669d.jpg)
U.S. move to negotiate drug prices a rare defeat for Big Pharma
U.S. move to negotiate drug prices a rare defeat for Big Pharma
Hiltzik: The flaws in Medicare drug price negotiation - Los
Biden administration targets 10 drugs for Medicare cost negotiations
What's next for drug pricing in 2023
Medicare price negotiation: Putnam's round one picks - Putnam
How Pharma Lost Its Edge in Washington - Bloomberg
Big Pharma Drops Over $100 Million Fighting Prescription Drug
de
por adulto (o preço varia de acordo com o tamanho do grupo)
